Xtide 100mg Injection
Marketer
Biocon
Salt Composition
Oxaliplatin (100mg)
Overview Xtide 100mg Injection
Oncotide, a 100mg injectable solution, combats colorectal cancer by inhibiting cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse effects. While therapeutic benefits may take weeks or months to manifest, discontinuation should only occur under medical guidance. Common side effects include nausea, tiredness, vomiting, and diarrhea. A reduction in blood cell counts, increasing infection risk, is possible. Serious allergic reactions, such as mouth sores, rash, itching, and respiratory distress, necessitate immediate medical attention. Regular blood tests monitoring blood cell counts, heart, liver function, and uric acid levels are mandatory. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, especially those for infections, as drug interactions are possible. Use during pregnancy or breastfeeding is contraindicated. Due to potential infertility in males, sperm cryopreservation should be discussed with a doctor. Post-injection dizziness necessitates avoidance of driving.
Uses of Xtide 100mg Injection
Colorectal cancer
Major Benefits of Xtide 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Xtide 100mg Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Xtide 100mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Xtide 100mg Injection works:
Oncaspar (100mg injection) is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of malignant cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with Xtide 100mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Xtide 100mg Injection during pregnancy poses a confirmed risk to fetal development, precluding its routine use. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential advantages outweigh the inherent dangers. Medical advice is essential.
Breast feedingUNSAFE
Administration of Xtide 100mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administration of Xtide 100mg Injection or Oxaliplatin can induce adverse reactions, including dizziness, nausea, vomiting, and other neurological symptoms impacting gait. These effects may impair driving ability.
KidneyCAUTION
Exercise caution when administering Xtide 100mg Injection to individuals with severe renal impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Xtide 100mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney dysfunction.
LiverCAUTION
Administering Xtide 100mg Injection to individuals with hepatic impairment requires careful consideration. Dosage modification of Xtide 100mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Xtide 100mg Injection :
Should you forget a dose of Xtide 100mg Injection, seek your physician's advice.
Facts to Know About Xtide 100mg Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based antineoplastic agents |
3,018 People bought this recently